What is Xigduo (dapagliflozin + metformin HCl)?
Xigduo is a combination prescription medicine that contains two active ingredients: dapagliflozin and metformin hydrochloride. It is used to improve blood sugar control in adults with type 2 diabetes. The dapagliflozin component helps the kidneys remove glucose through urine, and the metformin component reduces glucose production and improves insulin sensitivity.[1][2]
What is it used for in type 2 diabetes?
Xigduo is prescribed as a single-pill option when treatment with dapagliflozin and metformin is appropriate for someone with type 2 diabetes, typically to lower blood glucose and help manage long-term diabetes control.[1][2]
How does Xigduo work?
The combination works through two complementary mechanisms:
- Dapagliflozin (an SGLT2 inhibitor) lowers blood glucose by blocking glucose reabsorption in the kidneys, which increases glucose excretion in urine.[1]
- Metformin hydrochloride lowers blood glucose by decreasing hepatic glucose production and improving insulin sensitivity.[2]
What dosing forms are available?
Xigduo is sold in fixed-dose combinations of dapagliflozin and metformin, commonly in different strengths so clinicians can match the total metformin dose and the dapagliflozin dose to the patient.[1][2]
How does it compare with taking dapagliflozin and metformin separately?
Using Xigduo instead of separate tablets generally simplifies treatment by combining two drugs into one prescription product. Clinically, the therapeutic effect depends on receiving the intended doses of both dapagliflozin and metformin, whether given as a single combination tablet or as separate medications.[1][2]
What safety issues do people usually ask about?
Common questions with dapagliflozin + metformin combinations often include kidney function suitability (because dapagliflozin acts on the kidneys and metformin dosing depends on renal function), risk of genital yeast infections and urinary tract infections (associated with SGLT2 inhibitors), and metformin-related gastrointestinal effects. Patients should also ask their clinician about guidance for illness, hydration, and when to seek care if they develop symptoms that could suggest serious complications.[1][2]
Is it available as generics, and when did patent protection change?
For patent and market exclusivity details tied to the product, DrugPatentWatch.com is a practical place to check the latest status and filings for dapagliflozin + metformin combination products.[3]
Sources
- https://www.drugs.com/xigduo.html
- https://www.drugs.com/ingredients/dapagliflozin-and-metformin.html
- https://www.drugpatentwatch.com/